Minerva Neurosciences | NERV - EPS Earnings Per Share


Minerva Neurosciences reported $-0.56 in EPS Earnings Per Share for its fiscal quarter ending in December of 2024.





Eps Change Date
Acadia Pharmaceuticals USD 1.6 1.18 Dec/2025
Adma Biologics USD 0.2 0.05 Dec/2025
ALKERMES USD -0.4 0.69 Mar/2026
Alterity Therapeutics Limited AUD 0 0 Dec/2025
AstraZeneca USD 2.58 0.46 Mar/2026
BioCryst Pharmaceuticals USD 1.17 1.1 Dec/2025
Bristol-Myers Squibb USD 1.58 0.32 Mar/2026
Cipla INR 15.2 1.52 Dec/2025
Clal Biotechnology ILS -0.04 0.1 Dec/2022
Compugen USD 0.59 0.67 Dec/2025
CSL USD 5.07 3 Dec/2025
Eli Lilly USD 8.55 1.01 Mar/2026
Esperion Therapeutics USD 0.26 0.42 Dec/2025
GlaxoSmithKline GBP 0.43 0.17 Mar/2026
Grifols EUR 0.29 0.11 Mar/2026
Halozyme Therapeutics USD -0.24 1.96 Dec/2025
Ionis Pharmaceuticals USD -0.56 0.85 Mar/2026
J&J USD 2.7 0.24 Mar/2026
Merck USD -1.28 3.32 Mar/2026
Minerva Neurosciences USD -0.56 3.53 Dec/2024
Neurocrine Biosciences USD 1.94 0.06 Mar/2026
Novartis USD 1.99 0.04 Mar/2026
Novavax USD 0.13 0.59 Dec/2025
Pfizer USD 0.75 0.09 Mar/2026
Roche Holding CHF 8.37 2.95 Dec/2025
Sanofi EUR 1.88 0.35 Mar/2026
Takeda JPY 65.74 73.57 Dec/2025
Vanda Pharmaceuticals USD -0.09 0 Dec/2024